All Stories

  1. Discrepancies in reference values of soluble Triggering Receptor Expressed on Myelocytes 1 (sTREM-1) question the reliability of related studies
  2. Giant cell arteritis and systemic sclerosis: a rare overlap syndrome
  3. The influence of therapy on CD4+CD25highFOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study
  4. Increase of peripheral T regulatory cells during remission induction with cyclophosphamide in active systemic lupus erythematosus
  5. Tocilizumab Treatment Leads to a Rapid and Sustained Increase in Treg Cell Levels in Rheumatoid Arthritis Patients: Comment on the Article by Thiolat et al
  6. FRI0416 Cd4+Cd25high Foxp3+ T Regulatory Cells and Related Cytokines (IL-6, IL-10, TGF-β) in Neuropsychiatric Systemic Lupus Erythematosus
  7. AB0492 The Influence of Therapy on CD4+Cd25highfoxp3+ T Regulatory Cells in Systemic Lupus Erythematosus Patients: A Prospective Study
  8. Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? A critical appraisal
  9. T Regulatory Cells: A Promising New Target in Atherosclerosis
  10. Systemic Sclerosis and Silicone Breast Implant: A Case Report and Review of the Literature
  11. Celiac trunk aneurysm in a patient with Adamantiades-Behçet disease
  12. Fatal Refractory Thrombotic Thrombocytopenic Purpura Complicating Systemic Lupus Erythematosus
  13. FRI0280 Cd4+cd25highfoxp3+ t regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study
  14. OP0117 Cyclophosphamide Pulse Therapy Leads to T Regulatory Cells Alterations in Active Systemic Lupus Erythematosus
  15. ADAMTS-13 metalloprotease abnormalities in systemic lupus erythematosus: is there a correlation with disease status?
  16. Immunopathophysiology of Large Vessel Involvement in Giant Cell Arteritis — Implications on Disease Phenotype and Response to Treatment
  17. T Regulatory Cells and Helicobacter pylori-Associated Diseases
  18. The Role of Anti-Phosphatidylserine/Prothrombin Antibodies in Thrombotic Manifestations of Systemic Lupus Erythematosus Patients
  19. PLATELET-DERIVED MICROPARTICLES MAY CONTRIBUTE TO THE THROMBOTIC TENDENCY IN SYSTEMIC LUPUS ERYTHEMATOSUS BY BOTH PROCOAGULANT AND IMMUNE-MEDIATED MECHANISMS
  20. IMMUNE REGULATION IN LUPUS NEPHRITIS: ROLE OF CD4+CD25high FOXP3+ T REGULATORY CELLS AND RELATED CYTOKINES (IL-6, IL-10, TGF�)
  21. Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report
  22. Immunopathogenesis Based Adamantiades- Behcet Disease Vasculitis Treatment
  23. Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report
  24. Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature
  25. Chronic Brucellosis Patients Retain Low Frequency of CD4+ T-Lymphocytes Expressing CD25 and CD28 afterEscherichia coliLPS Stimulation of PHA-Cultured PBMCs
  26. PO19-538 SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX (SLEDAI) AFFECTS CARDIOVASCULAR RISK: EXPERIENCE FROM A GREEK CENTER
  27. YI-845 CD40/CD40L IN DYSLIPIDEMIC PATIENTS WITH RHEUMATOID ARTHRITIS (RA). THE IMMUNOMODULATING EFFECT OF SIMVASTATIN
  28. Concurrent relapsing central nervous system and ocular involvement in a case of life-threatening Adamantiades-Behçet Disease (ABD)
  29. Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case